• Fund Type: Open-End Fund
  • Objective: Value Broad Market
  • Asset Class: Equity
  • Geographic Focus: U.K.

Saracen Global Income and Growth Fund

+ Add to Watchlist

SARGIGA:LN

1.30 GBP 0.01 1.08%

As of 00:59:30 ET on 08/22/2014.

Snapshot for Saracen Global Income and Growth Fund (SARGIGA)

Year To Date: +2.94% 3-Month: +0.22% 3-Year: +16.62% 52-Week Range: 1.23 - 1.36
1-Month: +1.66% 1-Year: +5.85% 5-Year: - Beta vs ASX: 0.90

Mutual Fund Chart for SARGIGA

No chart data available.
  • SARGIGA:LN 1.30
  • 1M
  • 1Y
Interactive SARGIGA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for SARGIGA

Saracen Global Income and Growth Fund is an open-end fund incorporated in the United Kingdom. The Fund aims to achieve a long-term total return on the invested assets at a higher rate than the total return on the FTSE All-Share Index. The Fund invests in a diversified portfolio of primarily UK equity securities which provide the potential for long-term growth.

Inception Date: 06-07-2011 Telephone: 44-141-248-2277
Managers: GRAHAM H CAMPBELL / DANIEL LEAF
Web Site: www.saracenfundmanagers.com

Fundamentals for SARGIGA

NAV (on 2014-08-27) 1.30
Assets (M) (on 2014-08-27) 40.81
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment -

Dividends for SARGIGA

Dividend Type Income
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-07-01) 3.14
Dividend Yield (ttm) 3.23

Fees & Expenses for SARGIGA

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.75
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for SARGIGA

Filing Date: 07/31/2014
Name Position Value % of Total
Novartis AG 22,842 1,184,000 3.200%
HSBC Holdings PLC 151,163 962,000 2.600%
Sanofi 15,436 962,000 2.600%
SES SA 39,108 851,000 2.300%
Aviva PLC 169,017 851,000 2.300%
Cie de St-Gobain 29,472 851,000 2.300%
SKF AB 60,726 851,000 2.300%
Roche Holding AG 4,934 851,000 2.300%
Royal Dutch Shell PLC 33,347 814,000 2.200%
Unilever NV 31,526 777,000 2.100%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil